Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, As Represented By”

2,152 pharma patents match "The United States of America, As Represented By" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,152
Index total 30,257
Page 35 / 90

Quick answer

This filtered view shows 2,152 pharmaceutical patents matching "The United States of America, As Represented By" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,152 results for “The United States of America, As Represented By” · 30,257 patents in full index Clear search

  1. US 9725492

    Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted

  2. US 9717752

    Uses of antagonists of hyaluronan signaling

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 1, 2017 · Expires Jul 27, 2037

    granted

  3. US 9719080

    Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class methylmalonic acidemia (MMA)

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 1, 2017 · Expires Jul 27, 2037

    granted

  4. US 9707220

    Scopolamine for the treatment of depression and anxiety

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  5. US 9708392

    Monoclonal antibodies against orthopoxviruses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  6. US 9708267

    Activators of human pyruvate kinase

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  7. US 9707230

    Activators of human pyruvate kinase

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  8. US 9707283

    Genetically modified babesia parasites expressing protective tick antigens and uses thereof

    The United States of America, as represented by the Secretary of Agriculture · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  9. US 9707287

    Attenuated mutant dengue viruses comprising a mutation in the NS4B non-structural protein

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted

  10. US 9701718

    Adenovirus serotype 26 and serotype 35 filovirus vaccines

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted

  11. US 9700562

    Triazine compounds and compositions thereof and methods for treating malaria and chemoprophylaxis

    The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted

  12. US 9695230

    Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 4, 2017 · Expires Jun 29, 2037

    granted

  13. US 9688739

    T cell receptors and related materials and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 27, 2017 · Expires Jun 22, 2037

    granted

  14. US 9683269

    Infectious hepatitis C viruses of genotype 3A and 4A and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted

  15. US 9683263

    Detection and treatment of irritable bowel syndrome

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted

  16. US 9676857

    Soluble engineered monomeric Fc

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted

  17. US 9676788

    Aza-epoxy-guaiane derivatives and treatment of cancer

    The United States of America, as represented by the Secretary, Health and Human Services · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted

  18. US 9676846

    Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted

  19. US 9676771

    Compounds for inhibiting drug-resistant strains of HIV-1 integrase

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted

  20. US 9670549

    Gene expression signatures of neoplasm responsiveness to therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted

  21. US 9663521

    Compounds and methods for the prevention and treatment of tumor metastasis and tumorigenesis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 30, 2017 · Expires May 25, 2037

    granted

  22. US 9663485

    Tocopherol and tocopheryl quinone derivatives as correctors of Lysosomal Storage Disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 30, 2017 · Expires May 25, 2037

    granted

  23. US 9655366

    Volatile blends and the effects thereof on the navel orangeworm moth

    The United States of America, as represented by the Secretary of Agriculture · Granted May 23, 2017 · Expires May 18, 2037

    granted

  24. US 9657292

    Compositions and methods for treating or preventing lupus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 23, 2017 · Expires May 18, 2037

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.